Fauci’s NIAID Funded Wuhan Lab Scientists To Research Bat Coronavirus

NOTE: This article was originally published on April 13, 2020, and was updated again on April 30, 2020. It was the first article reporting that NIAID funded the Bat Coronavirus project.

2002 Playmate of the Year Dalene Curtis retweeted the story on April 19, 2020.

Fauci’s NIAID Funded Wuhan Lab Scientists To Research Bat Coronavirus – National File #FauciTheFraud #COVID19 https://t.co/9adWgd1XU7

— Dalene Kurtis (@DaleneKurtis) April 19, 2020

Dr. Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) actually funded a study on Bat Coronavirus, which was a project that included scientists at the Wuhan Institute of Virology, the Chinese lab at the center of controversy over their bat research. That study confirmed in 2018 that humans have died from coronavirus.

(RELATED: Read The FULL STORY of FAUCI and BILL GATES).

Here’s an excerpt from the April 4, 2018 NIAID website entry entitled “New Coronavirus Emerges From Bats in China, Devastates Young Swine”: “A newly identified coronavirus that killed nearly 25,000 piglets in 2016-17 in China emerged from horseshoe bats near the origin of the severe acute respiratory syndrome coronavirus (SARS-CoV), which emerged in 2002 in the same bat species. The new virus is named swine acute diarrhea syndrome coronavirus (SADS-CoV). It does not appear to infect people, unlike SARS-CoV which infected more than 8,000 people and killed 774. No SARS-CoV cases have been identified since 2004. The study investigators identified SADS-CoV on four pig farms in China’s Guangdong Province. The work was a collaboration among scientists from EcoHealth Alliance, Duke-NUS Medical School, Wuhan Institute of Virology and other organizations, and was funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The research is published in the journal Nature. The researchers say the finding is an important reminder that identifying new viruses in animals and quickly determining their potential to infect people is a key way to reduce global health threats.”